Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? A Systematic Review and Meta-Analysis

  • Lopes E
  • Heineck I
  • Athaydes G
 et al. 
  • 21


    Mendeley users who have this article in their library.
  • 11


    Citations of this article.


The aim of this study was to assess drug use and costs before and after bariatric surgery (BS). A systematic review of the literature was carried out using the MeSH terms obesity, bariatric surgery, and drug costs for searches of 10 electronic databases up to July 2014. Data were extracted from the 11 studies (37,720 patients) that fulfilled the inclusion criteria. Where applicable, data were pooled by meta-analysis. The average number of drugs per patient decreased from 3.9 ± 1.86 before surgery to 1.75 ± 1.85 after surgery. Mean reduction in total cost of drugs was 49.8 % over a follow-up duration of 6-72 months. BS is effective for the improvement or resolution of comorbidities and significantly reduces drug use and costs.

Author-supplied keywords

  • Bariatric surgery
  • Cost analysis
  • Drug costs
  • Meta-analysis
  • Pharmacoepidemiology

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • E. C. Lopes

  • I. Heineck

  • G. Athaydes

  • N. G. Meinhardt

  • K. E P Souto

  • A. T. Stein

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free